SCHEMBL31437092

SCHEMBL31437092

CC(C)(C)OC(=O)N1CCCCC1CNc1ccccc1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.52
PRMT5 O14744 1/20 0.48
OPRD1 P41143 1/20 0.47
PDE8B O95263 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HDAC1 Q13547 6/20 0.45
TRPV1 Q8NER1 1/20 0.42
FPR3 P25089 1/20 0.42
FPR2 P25090 1/20 0.42
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
GLA P06280 1/20 0.41
AHCY P23526 1/20 0.41
METTL3 Q86U44 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC2 Q92769 1/20 0.41
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15575388 0.97 OPRD1 (0.50) KDM1APRMT5OPRD1PDE8BMEN1
SCHEMBL4471009 0.84 MEN1 (0.46) KDM1APDE8BMEN1KMT2AHDAC1
SCHEMBL2200178 0.83 OPRD1 (0.50) KDM1APRMT5OPRD1MEN1KMT2A
SCHEMBL16333400 0.82 KDM1A (0.49) KDM1APRMT5OPRD1PDE8BMEN1
SCHEMBL19540688 0.82 APP (0.49) KDM1AOPRD1HDAC1FPR3FPR2
SCHEMBL1462901 0.82 FPR3 (0.50) KDM1APRMT5OPRD1MEN1KMT2A
SCHEMBL29825424 0.81 NPC1 (0.43) KDM1APRMT5OPRD1MEN1KMT2A
SCHEMBL19141219 0.81 PRMT5 (0.53) KDM1APRMT5OPRD1PDE8BTRPV1
SCHEMBL5337684 0.81 PRMT5 (0.53) KDM1APRMT5OPRD1PDE8BTRPV1
SCHEMBL13889153 0.81 PTGER4 (0.42) KDM1APRMT5OPRD1PDE8BTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119630644-A Bifunctional compounds containing pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed
CN-119630651-A Bifunctional compounds containing substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed